Radiotherapy is the only standard of care for H3K27M mutant diffuse midline glioma. Unfortunately, following initial response tumors recur. Experimental therapeutics can synergize with radiotherapy to produce a greater therapeutic effect than either agent alone, a concept known as 'radiosensitization'. Our team has pioneered this concept both in the laboratory and clinic including in successful bench-to-bedside translational studies in patients with brain tumors.

The Regents of the University of Michigan
Fleming Administration Bldg, 503 Thompson St
Ann Arbor, MI 48109
United States